CJC 1295 + IPA
A fixed 5 mg / 5 mg CJC-1295 + ipamorelin research blend for laboratory studies of GHRH- and ghrelin-receptor signaling. The exact CJC-1295 variant must be confirmed before technical metadata is published.
- Product
- CJC 1295 + IPA
- Quantity
- 5 mg / 5 mg
- Form
- Lyophilized blend - verify Syntide COA
- Presentation
- Vial
- SKU
- SA-CJCIPA-5-5
For research use only.
Not for human or veterinary consumption.
CJC 1295 + IPA / 5 mg / 5 mg
CJC-1295 variant + Ipamorelin is presented as 5 mg / 5 mg for laboratory research use. Product specifications and any available documentation are provided on this page.
Research context: GHRH-receptor signaling, ghrelin/GHSR signaling, receptor-interaction studies, dual-pathway endocrine signaling models. Do not publish claims about raising GH, physique, recovery, or performance.
Product data
- Compound
- CJC-1295 variant + Ipamorelin
- Quantity
- 5 mg / 5 mg
- Category
- Peptide Blends
- Form
- Lyophilized blend - verify Syntide COA
- Presentation
- Vial
- SKU
- SA-CJCIPA-5-5
Quality & documentation
Available files are shown from the current documentation record for this product. Availability may vary by product or batch.
Available where provided
Documentation for this product is not currently available online. Contact support for assistance.
Order information
Shipping
Orders are processed according to the Syntide Aminos Shipping Policy.
Research catalog
Explore additional compounds and supplies within the Syntide Aminos research catalog.
GLOW
70 mg
$70.00
KLOW
80 mg
$70.00
BAC WATER
10 mL
$70.00
BPC-157
10 mg
$70.00
RESEARCH USE NOTICE
Products offered by Syntide Aminos are intended solely for laboratory and research purposes. They are not intended for human or veterinary consumption and are not intended to diagnose, treat, cure or prevent any disease.
Product information provided on this website is for identification, specification and research-reference purposes only and should not be interpreted as medical advice or instructions for human use.
READ FULL RESEARCH USE DISCLAIMER